GL1X · GenesisL1 explorer

MolNFT v1 · #48506 · protein

Structure-based design of PYRAZOLO[1,5-A][1,3,5]TRIAZINE derivatives as potent inhibitors of protein kinase CK2

2PVH · Casein kinase II subunit alpha: “Structure-based design of PYRAZOLO[1,5-A][1,3,5]TRIAZINE derivatives as potent inhibitors of protein kinase…”. X-ray diffraction, 1 ligand (P19), 2 pockets (best druggability 0.69). MolNFT v1 #48506…

PDB
2PVH
Type
protein
Length
328 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Casein kinase II subunit alpha
EC
2.7.11.1
UniProt
P28523
Ligands
P19
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACasein kinase II subunit alpha (EC 2.7.11.1)protein32843% helix, 15% strandP28523

Ligands and binding sites

  • P19 · N,N'-diphenylpyrazolo[1,5-a][1,3,5]triazine-2,4-diamine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13400.690.8250P19
2510.290.7614empty

Modifications

Observed in the structure: 1 modified (oxidation).

Compared structures

  • 2PVH · Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors… · the same entry in another collection · chain A against A, TM-score 1.00
  • P28523 · AlphaFold monomer V2.0 prediction for casein kinase II subunit alpha (P28523) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.